News
England's National Health Service said Friday it is the first health system in the world to offer a targeted blood cancer ...
A “TROJAN HORSE” therapy that sneaks toxic drugs inside and kills cancer cells is being rolled out on the NHS in England in a ...
England’s NHS has launched a groundbreaking “Trojan Horse” therapy for the treatment of myeloma, offering hope for thousands ...
9h
Pharmaceutical Technology on MSNNICE approves GSK’s belantamab mafodotin for blood cancer"NICE approves GSK’s belantamab mafodotin for blood cancer" was originally created and published by Pharmaceutical Technology ...
NHS patients in the UK suffering from blood cancer could have their lives prolonged by a groundbreaking new drug ...
The targeted therapy can stop myeloma from progressing by nearly three times as long as existing treatments, studies suggest.
Blood cancer patients in England will be the first in the world to be offered a 'Trojan horse' drug. Thousands of patients ...
A "Trojan horse" therapy that sneaks toxic drugs inside cancer cells is being made available on the NHS in England in a world first. It can halt the blood cancer myeloma for nearly three times ...
It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...
The NHS in England will be the first health system in the world to roll-out a ‘trojan horse’ targeted therapy for blood cancer patients which could halt the disease’s progression by nearly three times ...
UK's health authorities will offer a new targeted treatment for patients suffering from an aggressive blood cancer. This ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results